文献速递脑血管病

化学交换饱和转移磁共振成像用于3T小鼠模型脑出血及去铁胺治疗的纵向评估

Chemical Exchange Saturation Transfer Magnetic Resonance Imaging for Longitudinal Assessment of Intracerebral Hemorrhage and Deferoxamine Treatment at 3T in a Mouse Model.
PubMed 文献 · Stroke · 2022-11-23

研究在胶原酶诱导的脑出血小鼠模型中,于3T下应用化学交换饱和转移(CEST)磁共振成像纵向监测血肿分子改变,并评估去铁胺治疗的影响。结果显示,-3.5 ppm的rNOE对比在去铁胺治疗后第3天显著降低25.7%(P<0.05),且rNOE主要与髓鞘病理相关,酰胺质子转移可反映血肿细胞密度增加。

要点

  • CEST成像可在14天内无创监测小鼠脑出血血肿的分子变化及去铁胺治疗反应。
  • 去铁胺治疗后第3天,rNOE对比显著降低25.7%(P<0.05),酰胺质子转移对比未见此变化。
  • rNOE主要与髓鞘病理相关,酰胺质子转移可反映血肿细胞密度增加至第7天。

核心结论

  • rNOE的显著变化与组织学 findings 尤其髓鞘脂质相关性良好,血肿区域特征表明CEST磁共振成像在监测脑出血及治疗期间分子变化方面具有独特性。

研究设计与样本

  • 在胶原酶诱导的脑出血小鼠模型中,于3T下纵向(14天)检测3.5 ppm酰胺质子转移和-3.5 ppm rNOE对比,并用免疫组织化学验证影像发现。
  • 另检测含铁体模以确认铁不会在疾病进展中衰减CEST对比,并进一步在去铁胺铁螯合治疗下检查相关分子改变。

主要发现

  • 观察到-3.5 ppm rNOE与3.5 ppm酰胺质子转移对比的时空差异:rNOE可在第3天和第14天识别核心和血肿周围区,酰胺质子转移可在第1天、第7天和第14天识别。
  • 去铁胺治疗脑出血小鼠后第3天,rNOE对比显著降低25.7%(P<0.05),而酰胺质子转移对比未见此变化。
  • 组织学数据显示rNOE主要与髓鞘病理相关,酰胺质子转移可反映血肿细胞密度增加至第7天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Noninvasive imaging of molecular alterations after intracerebral hemorrhage (ICH) could provide valuable information to guide and monitor treatments. Chemical exchange saturation transfer (CEST) magnetic resonance imaging has demonstrated promises in identifying proliferation, necrosis, and changes in cellularity in brain tumors. Here, we applied CEST magnetic resonance imaging to monitor molecular changes in hematoma without and with treatment noninvasively over 2 weeks at 3T using endogenous contrast. METHODS: CEST contrast related to proteins at 3.5 ppm (amide proton transfer) and proteins/lipids at -3.5 ppm (relayed nuclear overhauser effect [rNOE]) were examined over 14 days in a collagenase-induced ICH mouse model. Imaging findings were validated with immunohistochemistry based on the ICH neuropathology. We also examined iron-containing phantoms that mimicked iron concentrations in hematoma to ensure the iron will not attenuate the CEST contrast during disease progression. Based on the validity of the CEST contrast of hematoma, we further examined related molecular alterations under iron-chelation treatment with deferoxamine. RESULTS: We observed the temporal and spatial differences of CEST contrasts between rNOE at -3.5 ppm and amide proton transfer at 3.5 ppm, in which the core and perihematoma could be identified by rNOE on day 3 and day 14, and amide proton transfer on day 1, day 7, and day 14. Moreover, we observed a 25.7% significant reduction (P<0.05) of rNOE contrast after deferoxamine treatment to the ICH mice on day 3, which was not observable in amide proton transfer contrast. Our histology data indicated that rNOE primarily correlated with the myelin pathology, and amide proton transfer could reflect the cellularity increase at hematoma up to day 7. CONCLUSIONS: Significant rNOE changes correlated well with histologic findings, especially myelin lipids, and regional characteristics in hematoma indicate the uniqueness of CEST magnetic resonance imaging in monitoring molecular changes during ICH and treatment.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lai JHC, Liu J, Yang T, et al. Chemical Exchange Saturation Transfer Magnetic Resonance Imaging for Longitudinal Assessment of Intracerebral Hemorrhage and Deferoxamine Treatment at 3T in a Mouse Model. Stroke. 2022. PMID: 36416125. doi:10.1161/STROKEAHA.122.040830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。